Abstract
The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.
Publication types
-
Controlled Clinical Trial
MeSH terms
-
Aged
-
Antiparkinson Agents / therapeutic use*
-
Dopamine Agents / therapeutic use*
-
Female
-
Gambling*
-
Humans
-
Levodopa / therapeutic use*
-
Male
-
Middle Aged
-
Ontario / epidemiology
-
Parkinson Disease / drug therapy*
-
Parkinson Disease / epidemiology*
-
Prevalence
-
Prospective Studies
-
Risk Assessment / methods*
-
Risk Factors
Substances
-
Antiparkinson Agents
-
Dopamine Agents
-
Levodopa